Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCCYanli Yao, Shuyang Sun|Signal Transduction and Targeted Therapy|2022Cited by 37